Harrow, Inc

HROWNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

37.5M

on 2026-06-30, from 35.4M on 2024-03-31 10-Q ↗

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

1 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-10 is not read yet.

Cash

$83.9M

Operating cash flow was positive over the four quarters to 2026-06-30, so no quarters are counted. 10-Q ↗

Raised: 2 of its filings are not read yet.